Peter Blume-Jensen - President and CEO, Director at Acrivon Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: President and CEO, Director
Issuer Symbol: ACRV on Nasdaq
All Insider Reports: All Insider Reports

Peter Blume-Jensen - trading volume in the past year for Acrivon Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+49,000	100%	$1.68	+$82,124
Sells
Net	+49,000	100%		+$82,124

Holdings reported by Peter Blume-Jensen for Acrivon Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	2,080,204	$3,182,712	$1.53	21 Feb 2026	Direct
Common Stock	314,127	$609,406	$1.94	21 Feb 2026	Indirect
Stock Option (Right to Buy)	390,390			01 Mar 2025	Direct	Common Stock
Stock Option (Right to Buy)	140,540			01 Mar 2025	Indirect	Common Stock

Transactions reported by Peter Blume-Jensen for Acrivon Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.